Selective eradication of leukemic (L-CFU) versus normal (CFU-GM) myeloid progenitors in suspension culture utilizing a prolonged exposure to 1-B-D arabinofuranosylcytosine (Ara-C) and deoxycytidine (dCyd)
Grant, S.; Howe, C.; Kuczynski, T.
Progress in Clinical and Biological Research 333: 69-77
1990
ISSN/ISBN: 0361-7742 PMID: 2309002 Document Number: 366038
Document emailed within 1 workday
Related Documents
Liesveld, J.L.; Winslow, J.M.; Kempski, M.C.; Ryan, D.H.; Brennan, J.K.; Abboud, C.N. 1991: Adhesive interactions of normal and leukemic human CD34+ myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components Experimental Hematology 19(1): 63-70Stegmann, A.P.; Honders, M.W.; Kester, M.G.; Landegent, J.E.; Willemze, R. 1993: Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine Leukemia 7(7): 1005-1011
Bhalla, K.; Nayak, R.; Grant, S. 1984: Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine Cancer Research 44(11): 5029-5037
Momparler, R.L.; Doré, B.T.; Labiberté, J.; Momparler, L.F. 1993: Interaction of 5-aza-2'-deoxycytidine with amsacrine or 1,25-dihydroxyvitamin D3 on HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase Leukemia 7(Suppl 1): 17-20
Wahren, B.; Gahrton, G.; Hammarström, S. 1980: Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients Cancer Research 40(6): 2039-2044
Nara, N.; Yamashita, Y.; Murohashi, I.; Tanikawa, S.; Imai, Y.; Aoki, N. 1987: Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin Cancer Research 47(9): 2376-2379
Grant, S.; Rauscher, F.; Cadman, E. 1982: Differential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors Cancer Research 42(10): 4007-4013
Lemoli, R.M.; Visani, G.; Gobbi, M.; Rizzi, S.; Dinota, A.; Tassi, C.; Tosi, P.; Galieni, P.; Cavo, M.; Tura, S. 1989: Normal myeloid progenitors (CFU-GM) in multiple myeloma: a preliminary study in view of autologous BMT Bone Marrow Transplantation 4(4): 373-377
Lemoli, R.M.; Visani, G.; Tosi, P.; Mazza, P.; Motta, M.R.; Rizzi, S.; Zinzani, P.L.; Poluzzi, C.; Gherlinzoni, F.; Tura, S. 1988: Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM) Haematologica 73(3): 195-200
Koeffler, H.P.; Amatruda, T.; Ikekawa, N.; Kobayashi, Y.; Deluca, H.F. 1984: Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues Cancer Research 44(12 Pt 1): 5624-5628
Honma, Y.; Onozuka, Y.; Okabe-Kado, J.; Kasukabe, T.; Hozumi, M. 1991: Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity Cancer Research 51(17): 4535-4538
Liliemark, J.O.; Plunkett, W. 1986: Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate Cancer Research 46(3): 1079-1083
Veselý, J.; Cihák, A. 1977: Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice Cancer Research 37(10): 3684-3689
Wilson, V.L.; Jones, P.A.; Momparler, R.L. 1983: Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action Cancer Research 43(8): 3493-3496
Umeda, M.; Shirai, T. 1989: Relationship between Ara-C sensitivity of leukemic-colony forming units (L-CFU) and [3H] deoxycytidine suicide test of L-CFU Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 52(3): 618-622
Suzuki, H.; Kim, S.H.; Tanara, M.; Okazaki, K.; Okabe, T.; Wu, R.T.; Tanaka, N. 1987: Potentiation of cytotoxicity of 1-beta-D-arabinofuranosylcytosine for K562 human leukemic cells by cadeguomycin Cancer Research 47(3): 713-717
Iwasaki, H.; Aoyama, H.; Ueda, T.; Uchida, M.; Nakamura, T. 1992: Morphologic differences in leukemic cells (L1210) exposed to 1-beta-D-arabinofuranosylcytosine and daunorubicin Anticancer Research 12(3): 941-947
Hoovis, M.L.; Chu, M.Y. 1973: Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y) Cancer Research 33(3): 521-525
Ross, D.D.; Joneckis, C.C.; Song, T.H.; Wu, R.K. 1988: Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells Cancer Research 48(3): 517-521
Pinto, A.; Zagonel, V.; Attadia, V.; Bullian, P.L.; Gattei, V.; Carbone, A.; Monfardini, S.; Colombatti, A. 1989: 5-Aza-2'-deoxycytidine as a differentiation inducer in acute myeloid leukaemias and myelodysplastic syndromes of the elderly Bone Marrow Transplantation 4(Suppl): 28-32